Site Contents Home Hosts and Sponsors Message from the Congress Key Addresses and Contacts Committee Schedule at a Glance General Information Visitor Information Program Features Social Program Exhibitors Congress Program Wed., June 6 Congress Program Thurs., June 7 Congress Program Fri., June 8 Congress Program Sat., June 9 Posters		Congress Program - Thursday, June 7   07:00 – 08:15 Interest Group Breakfast (tickets required) Plaza Ballroom 08:30 – 10:00 Plenary 3 Regency Ballroom Chair: Harvey Lui   08:30 – 09:00 Photosensitizers Kevin Smith 09:00 – 09:30 Optical Measurements for Quality Control During PDT Steven Jacques 09:30 – 10:00 Smart Dosimetry Brian Wilson 10:00 – 10:30 Refreshment Break/Exhibits/Posters Regency East 10:30 – 12:00 Plenary 4 Regency Ballroom   Chair: Harvey Lui   10:30 – 11:00 Clinical Applications of PDT in Thoracic Medicine Harubumi Kato 11:00 – 11:30 Clinical Applications of PDT in Dermatology Harvey Lui 11:30 – 12:00 Photodynamic Diagnosis and Photodynamic Therapy of Brain Tumors Herwig Kostron 12:00 – 13:30 Lunch Break/Exhibits/Posters Regency East 12:00 – 13:00 Annual General Meeting Regency Ballroom 13:30 – 15:00 Concurrent Symposia Plaza East Dermatology (1 of 2) Non-Oncologic Chairs: Robert Bissonnette & Rolf-Markus Szeimies   13:30 – 13:50 PDT for the Treatment of Psoriasis Robert Bissonnette 13:50 – 14:10 Photodynamic Therapy for Non-Oncologic Indications in Dermatology – Scerloderma, Sarcoidosis and HPV Related Dermatoses Rolf-Markus Szeimies 14:10 – 14:20 Effect of Irradiance and Fluence on the Epidermal Phototoxicity of ALA-PDT in Hairless Mouse Skin Robert Bissonnette 14:20 – 14:30 Quantitative Model Calculation of the Time Dependent Protoporphyrin Concentration in Normal Human Epidermis After Delivery of ALA By Passive Topical Application or Iontophoresis Willem M. Star 14:30 – 14:40 Induction of Collagenases in Human Dermal Fibroblasts by 5-Aminolevulinic Acid and Light Sigrid Karrer 14:40 – 14:50 In Vivo Evaluation of Human Melanin by Non-Invasive Raman Spectroscopy In Vitiligo Iltefat Hamzavi 14:50 – 15:00 Experiences of Studies on PDT for Port Wine Stains Jun-Heng Li Regency Ballroom Mechanisms of Action (2 of 3) Chair: Victor Fingar   13:30 – 13:40 Phthalocyanines: Structure Activity Relationship and Their Efficiency in the Photoinactivation of Microbial Pathogens Gabrio Roncucci 13:40 – 13:50 Photodynamic Therapy with Hypericin Induces Vascular Damage and Apoptosis in the RIF-1 Mouse Tumour Model Chen Bin 13:50 – 14:00 The Role of Complement in the Response of Tumors to Photodynamic Therapy Ivana Cecic 14:00 – 14:10 Effect of Fluence Rate on Photodynamic Therapy (PDT) Efficacy and Tumor Oxygenation in Meta-Tetra (Hydroxyphenyl)Chlorin (MTHPC) Sensitized Tumor-Bearing Mice Stephanie Coutier 14:10 – 14:20 Oxygen Levels During Continuous and Fractionated 5-Aminolaevulinic Acid (ALA) – Induced Photodynamic Therapy (PDT) of the Normal Rat Colon Alison Curnow 14:20 – 14:30 The Role of Reperfusion Injury in 5-Aminolaevulinic Acid (ALA) – Induced Photodynamic Therapy (PDT) of the Normal Rat Colon Alison Curnow 14:30 – 14:40 The Role of Neutrophils in ALA-PDT Henriette S. de Brujin 14:40 – 14:50 Scavenger Receptor-Targeted Photodynamic Therapy of Murine Tumors In Vivo Michael R. Hamblin 14:50 – 15:00 Elevation of HSP27 in PDT Induced Resistant Cancer Cells John G. Hanlon 15:00 – 15:10 Rapid Impairment of Serca2 and Emptying of Endoplasmic Reticulum Calcium Stores During PDT-Induced Apoptosis is Not Prevented by BCL-2 David W.C. Hunt Plaza Centre Upper GI (1 of 2) Chairs: Laurence Lovat & Bergein F. Overholt   13:30 – 13:50 Should We Treat Barrett’s Esophagus with PDT? Laurence Lovat 13:50 – 14:07 Combined Photodynamic Therapy and Hyperbaric Oxygenation in Carcinoma of the Esophagus and the Esophago-Gastric Junction Udo Anegg 14:07 – 14:24 Photodynamic Therapy in Early Oesophageal Cancer and Long Term Survival Luigi Corti 14:24 – 14:41 Green Light Foscan Photodynamic Therapy (PDT) on 25 Oesophageal Intramucosal Cancers (IMC) Jacques Etienne 14:41 – 15:01 PDT for Barrett’s Dysplasia – Results of Multicenter and Long Term Studies Bergein F. Overholt Plaza West Dosimetry (1 of 2) Chairs: Haishan Zeng & Willem Star   13:30 – 13:40 Correcting Relative Fluorescence Measurements for Optical-Property-Dependent Variations on the Optical Fiber Collection Efficiency Paulo R. Bargo 13:40 – 13:50 Fluorescence Photobleaching During 5-aminolevulinic Acid-Induced Protoporphyrin IX Photodynamic Therapy of the Normal Rat Liver W. Johannes de Wolf 13:50 – 14:00 Implicit Dosimetry: Relationship Between MTHPC Photobleaching and Cell Viability during In Vitro Photodynamic Therapy Jonathan S. Dysart 14:00 – 14:10 New Techniques for Determination of In Vivo Photosensitizer Concentration Using Diffuse Fluorescence and Reflectance Spectroscopy Robert A. Weersink 14:10 – 14:20 Multitasking Optical Fibre Probes for PDT Treatment Monitoring and Treatment Planning Lothar Lilge 14:20 – 14:30 Effect Monitoring of Neoadjuvant Therapy of Rectal Cancer by Delayed Laser-Induced Endogenous Fluorescence Detection Tim Handke 14:30 – 14:40 Inner-Filter Perturbations of Bacteriochlorin Fluorescence Photobleaching Measurements Emma C.A. Pittard 14:40 – 14:50 A Two-Phase Illumination Scheme in ALA-PDT: Improved Clinical Outcome? Peter D. Siersema 14:50 – 15:00 Investigation of Low Power Light and Light Fractionation for Enhancing PDT with mTHPC Hidemitsu Tsutsui 15:00 – 15:10 Spectrally Resolved Reflectance Imaging: Tissue Characterization and Non-Invasive Monitoring of Photodynamic Treatment of Cancer Sol Kimel Balmoral Room Urology / Gynecology (1 of 2) Chair: Ron Moore   13:30 – 13:50 Prostate Light Dosimetry John Tulip 13:50 – 14:02 In Vivo Photodynamic Activity of Hypericin in Heterotopic Transitional Cell Carcinoma Bladder Tumors Appolinary Kamuhabwa 14:02 – 14:14 Photodynamic Therapy (PDT) For Prostate Cancer: A Phase I Study in Locally Recurrent Disease After Radiotherapy Timothy R. Nathan 14:14 – 14:26 Biodistribution of Hypericin in Orthotopic Transitional Cell Carcinoma Bladder Tumors: Implication for its Photodynamic Therapy Appolinary Kamuhabwa 14:26 – 14:38 Phase I/II Clinical Test of Photodetection of Early Bladder Cancer with the Hexyl Ester of ALA Patrice Jichlinski 14:38 – 14:50 Phase III Trials for Early Bladder Cancer with h-ALA Bjorn Klem 15:00 – 15:30 Afternoon Break/Exhibits/Posters Regency East 15:30 – 17:00 Concurrent Symposia Regency Ballroom Optical Diagnosis (1 of 2) Chairs: Calum MacAulay & Kinya Furukawa   15:30 – 15:40 Bacteria-induced Fluorescence as a Disturbant Factor of Protoporphyrin IX - Fluorescence Diagnosis in the Oral Cavity W. Zenk 15:40 – 15:50 Fluorescence Diagnostic of Malignant Oral Lesions After Local ALA-Application W. Zenk 15:50 – 16:00 Localization of Small Non-Malignant and Malignant Lesions of the Colon by Laser-Induced Fluorescent Endoscopic (LIFE) Imaging Wojciech Cebula 16:00 – 16:10 Fluorescence Detection of Bladder Carcinoma After Intravesical Instillation With Hypericin Marie-Ange D’Hallewin 16:10 – 16:20 Simultaneous Prompt and Delayed Pulsed Laser-Induced Fluorimetry Quantifies Protoporphyrin IX Autofluorescence in Gastrointestinal Tumours Tim Handke 16:20 – 16:30 Measurements of NIR Raman Spectra of Skin In Vivo Using a Rapid Fiber Optic Raman Spectroscopy System Zhiwei Huang 16:30 – 16:40 Development and Clinical Application of High-Sensitive Fluorescence Detection System to Detect Cancer Lesion Using Fiber-Optic Endoscope Yoshinobu Ohsaki 16:40 – 16:50 Fluorescence Visualization with Blue Light More Accurately Estimates the Histopathologic Margins of Basal Cell Carcinoma as Compared to Clinical Examination Alone Harvey Lui Plaza East Biliary / Pancreatic /Lower GI Chairs: Norman Marcon & Stephen Hahn   15:30 – 15:50 PDT for Biliary Cancer Marianne Ortner 15:50 – 16:10 Phase II Study of Intraperitoneal Photodynamic Therapy for Patients with Overtly Disseminated Intraperitoneal Malignancies James M. Metz 16:10 – 16:22 Enhanced Mucosal Selectivity with m-THPC Using a Short Drug-Light Interval in the Rat Colon Neil F. Jamieson 16:22 – 16:34 Photodynamic Therapy for Cholangiocarcinoma Ian G. Renner Balmoral Room Neurosurgery Chairs: Paul Muller & John Hill   15:30 – 15:50 Clinical Trials in the Photodynamic Therapy of Primary Malignant Supratentorial Brain Tumors - Phase 2 and Phase 3 Studies Paul Muller 15:50 – 16:00 Human U87 Glioma Response to Photodynamic Therapy Using Photofrin in Combination with Buthionine Sulfoxine (BSO) Michael Chopp 16:00 – 16:10 Experimental Basis and Development of a Novel Intracranial Indwelling Balloon Light Applicator: Implications for Photodynamic Therapy in the Brain Henry Hirschberg 16:10 – 16:20 High-Dose Laser Irradiation and 5-Aminolevulinic Acid (5-ALA) for Photodynamic Therapy of Glioblastomas Albrecht Hochstetter 16:20 – 16:30 Intraoperative Photodynamic Diagnosis of Human Malignant and Benign Gliomas Using ALA Induced PpIX Sadao Kaneko 16:30 – 16:40 PDT Induced Apoptosis in the 9L Rat Glioma Model Lothar Lilge 16:40 – 16:50 Intraoperative Detection Of Malignant Brain Tumors By A Multispectral Fluorescence Guidance System Victor Yang Plaza West Photosensitizers (2 of 3) Chairs: Johan van Lier & Ravindra K. Pandey   15:30 – 15:50 PDT Tumor Response in the Rat: Real-Time Monitoring by FDG-PET Imaging Johan van Lier 15:50 – 16:10 HPPH-Aminophenyl DTPA [Gd(III)]-Conjugate: A Potential Tumor Diagnostic Agent for MRI and Photosensitizer for PDT Ravindra K. Pandey 16:10 – 16:20 Novel Strategies for the Construction of Targeted PDT Agents Using Porphyrin Isothiocyanates Oliver J. Clarke 16:20 – 16:30 The Application of Combinatorial Techniques in the Synthesis of Novel Photosensitizers Kerry J. Elgie 16:30 – 16:40 Acetylene-Substituted Phthalocyanine Analogues As New Photosensitisers For Photodynamic Therapy Rudiger Faust 16:40 – 16:50 Studies on Photodynamic Effects of Hydrophilic Photosensitizers, ATX-S10Na(II) and PAD-S31 Eiji Kohno 16:50 – 17:00 Improvement of PDT with Esterification of ALA: Influences on PPIX Accumulation, - Kinetics and - Phototoxicity René C. Krieg 17:00 – 17:10 MV6401: A New Potent Photosensitizer for Photodynamic Therapy Byron C. Robinson Plaza Centre Upper GI (2 of 2) Chairs: Ken Wang & Herbert Wolfsen   15:30 – 15:40 Photodynamic Therapy for Dysplastic Barrett’s Oesophagus: Long Term Follow Up Clive J. Kelty 15:40 – 15:50 Long-Term Survival After Photodynamic Therapy With Photofrin® For Early Gastric Cancer Seishiro Mimura 15:50 – 16:00 Endoscopic Photodynamic Therapy (PDT) in Inoperable Oesophageal Cancer Keyvan Moghissi 16:00 – 16:10 EMR-PDT for Gastric Cancer Hirojuki Narahara 16:10 – 16:20 Photodynamic Therapy for Gastric Cancer Yoshiro Nishiwaki 16:20 – 16:30 Optimization of Light Dosimetry During Photodynamic Therapy in the Esophagus: An Animal Study Alexandre Radu 16:30 – 16:40 Laser Therapy of Colorectal Cancer: Is There a Role for Photodynamic Therapy? Allan Weiss 16:40 – 16:50 P53 Mutations in Barrett’s Esophagus Predict Poor Response to Photodynamic Therapy Kenneth K. Wang 16:50 – 17:00 Photodynamic Therapy for Dysplastic Barrett’s Esophagus and Mucosal Esophageal Adenocarcinoma Herbert C. Wolfsen

Updated: May 27, 2001